HCXY Market Analysis

Overview

Fundamentals

P/E ratio19.45
EPS (TTM)0.0% YoY
Profit margin0.0%FINANCIALS
Market cap$1.31BSmall cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
5.0%
Beta
Last earnings
Oct 30, 2025 · Estimate $0.00 · Reported $0.63
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 49 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Hercules Capital, Inc.

Hercules Capital, Inc. (HCXY) is a prominent publicly traded business development company that specializes in providing customized financing solutions predominantly to enterprises in the life sciences and technology sectors. With a strong emphasis on capital preservation and risk-adjusted returns, Hercules combines its extensive industry expertise and strategic partnerships to deliver both debt and equity investments that fuel innovation and growth. The company's adept investment strategy effectively identifies high-potential firms within competitive markets, positioning Hercules as an…

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
NONE
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$1.31B
Shares outstanding$0
52W high$25.21
52W low$23.21

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer